Condition: Dementia · Alzheimer Disease · Dementia With Lewy Bodies · Sponsor: University Health Network, Toronto
To develop a model to predict disease progression in a large cohort of patients across a variety of neurodegenerative diseases, including Mild Cognitive Impairment (MCI) and dementia due to any neurodegenerative disease, including Alzheimer's Disease (AD), Lewy Body Disease (LBD), Vascular Disease (VaD) and Frontotemporal lobar degeneration (FTLD).
This description comes directly from the study's public registry record.
Claudia Clementi, HBSc · 416-603-5914 · claudia.clementi@uhn.ca
Always discuss trial participation with your own doctor first.
| Baycrest | North York, Ontario, Canada | Not Yet Recruiting |
| Sunnybrook Health Sciences Centre | Toronto, Ontario, Canada | Not Yet Recruiting |
| Toronto Western Hospital, University Health Network | Toronto, Ontario, Canada | Recruiting |
| Centre for Addiction and Mental Health | Toronto, Ontario, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06529744